|
|
The IMF is pleased to be able to bring you a webcast of the 12th International Myeloma Workshop in Washington, DC. |
|
|
|
|
|
| |
|
- 08:15-10:15 Multiple Myeloma - Molecular Pathways
- 10:30-12:30 Multiple Myeloma - Signaling Pathways
- 13:30-15:00 Myeloma Immune and Antibody Targets
- 15:30-17:30 Continuum Of Treatment in Multiple Myeloma: A Chronic Disease (Sponsored by Celgene)
|
|
|
|
 |
|
|
|
|
|
|
| |
|
- 07:00-08:00 Current Approaches to Supportive Care in Myeloma – Breakfast Symposium (Sponsored by Celgene)
- 08:15-10:15 Multiple Myeloma Microenvironment
- 10:30-12:30 Phase III Studies
- 13:30-15:00 Phase I/II Studies
- 13:30-15:00 Clinical - New Agents
- 13:30-15:00 Clinical - Basic Biology - Research
- 15:30-17:30 Complete Response As A Marker Of Patient Outcomes (Sponsored by Millennium/Ortho-Biotech)
|
|
|
|
|
|
|
|
|
|
|
| |
|
- 08:15-10:15 Consensus Panel
- 10:30-12:30 Transplant
- 13:30-15:00 Clinical - Phase II/III Studies
- 13:30-15:00 Clinical Care
- 13:30-15:00 Clinical - Basic Biology - Research II
- 15:30-17:30 Future Directions and Strategies in the Evaluation and Treatment of Clonal Plasma Cell Disorders (Sponsored by Celgene)
|
|
|
|
|
|
|
|
|
|
|
| |
|
- 08:15-10:15 Pro and Con Session
- 10:30-12:30 Phase II Studies
- 13:30-15:00 Plenary Session
- 15:30-17:30 Future Perspectives/Closing Ceremony
|
|
|
|
|
|
|
|
|
|
